Core Scientific, Inc.
CORZ
$22.79
-$0.16-0.70%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 85.14M | 37.60M | 23.67M | 16.20M | 12.35M |
| Total Other Revenue | 30.11M | 42.17M | 57.44M | 62.42M | 67.18M |
| Total Revenue | 115.24M | 79.76M | 81.10M | 78.63M | 79.53M |
| Cost of Revenue | 85.14M | 42.32M | 77.20M | 73.60M | 71.31M |
| Gross Profit | 30.11M | 37.45M | 3.91M | 5.03M | 8.21M |
| SG&A Expenses | 45.18M | 38.38M | 63.85M | 56.94M | 32.89M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 6.56M | 61.67M | -10.96M | -29.80M | 10.69M |
| Total Operating Expenses | 136.88M | 142.37M | 130.09M | 100.75M | 114.89M |
| Operating Income | -21.63M | -62.61M | -48.99M | -22.12M | -35.37M |
| Income Before Tax | -346.59M | 214.25M | -146.54M | -936.64M | 576.46M |
| Income Tax Expenses | 600.00K | 95.00K | 125.00K | 158.00K | 205.00K |
| Earnings from Continuing Operations | -347.19M | 214.15M | -146.66M | -936.80M | 576.25M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -347.19M | 214.15M | -146.66M | -936.80M | 576.25M |
| EBIT | -21.63M | -62.61M | -48.99M | -22.12M | -35.37M |
| EBITDA | -4.98M | -48.51M | -32.66M | -3.36M | -15.63M |
| EPS Basic | -1.06 | 0.59 | -0.46 | -0.84 | 1.42 |
| Normalized Basic EPS | -0.11 | 0.52 | -0.24 | -1.83 | 1.17 |
| EPS Diluted | -1.06 | 0.41 | -0.46 | -0.85 | 1.24 |
| Normalized Diluted EPS | -0.11 | 0.36 | -0.24 | -1.83 | 1.01 |
| Average Basic Shares Outstanding | 322.91M | 319.60M | 318.56M | 317.99M | 315.19M |
| Average Diluted Shares Outstanding | 322.91M | 464.57M | 318.56M | 317.99M | 363.31M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |